Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 252-385-1 | CAS number: 35121-60-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2017-04-13 to 2017-05-24
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- 2001
- Deviations:
- yes
- Remarks:
- Three groups were dosed at 300 mg/kg instead of the required two groups.
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- 10-methoxy-6-methylergoline-8β-methanol
- EC Number:
- 252-385-1
- EC Name:
- 10-methoxy-6-methylergoline-8β-methanol
- Cas Number:
- 35121-60-9
- Molecular formula:
- C17H22N2O2
- IUPAC Name:
- [(2S,4R,7R)-2-methoxy-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]methanol
Constituent 1
- Specific details on test material used for the study:
- Batch:16052R23A
Purity: >= 95%
Test animals
- Species:
- rat
- Strain:
- other: Crl: WI(Han)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
Source: Charles River Deutschland, Sulzfeld, Germany.
Age at study initiation: Young adult animals (approximately 8-10 weeks old) were selected.
Weight at study initiation: 144 to 194 g
Housing: On arrival and following assignment to the study, animals were group housed (up to 5 animals of the same sex and same dosing group together) in polycarbonate cages. containing sterilized sawdust as bedding material equipped with water bottles.
Diet: Pelleted rodent diet was provided ad libitum throughout the study, except during designated procedures.
Water: Municipal tap-water was freely available to each animal via water bottles.
Acclimation period: The animals were allowed to acclimate to the Test Facility toxicology accommodation for at least 5 days before the commencement of dosing.
ENVIRONMENTAL CONDITIONS
Temperature (°C): 18°C to 24°C (Target), 21 to 22°C (Actual)
Humidity (%): 40% to 70% (Target), 43 to 56% (Actual)
Air changes (per hr): Ten or greater
Photoperiod (hrs dark / hrs light): 12-hour light/12-hour dark cycle
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
Identification: Water (Elix)
Specific gravity: 1.0
Justification for choice of vehicle: Trial preparations were performed at the Test Facility to select the suitable vehicle and to establish a suitable formulation procedure.
CLASS METHOD
The dose levels are based on the OECD test guidelines and will be selected from the series 5 (lowest dose level), 50, 300 and 2000 (highest dose level) mg/kg body weight. The starting dose level should be the one that is likely to produce mortality in at least some of the animals
and will be selected based on available toxicity data of the test item. - Doses:
- 300 and 2000 mg/kg body weight
- No. of animals per sex per dose:
- Three females per group
- Control animals:
- no
- Details on study design:
- Duration of observation period following administration: 14 days
Frequency of observations and weighing: Mortality/Viability: Twice daily. Body weights: Days 1 (predose), 8 and 15. Clinical signs: at periodic intervals on the day of dosing (at least three times) and once daily thereafter.
Necropsy of survivors performed: yes, at the end of observation period, all animals were sacrificed by oxygen/carbon dioxide procedure and subjected to necropsy.
Other examinations performed: no.
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 300 - < 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- At 2000 mg/kg, all animals were found dead on Day 1 or 2.
At 300 mg/kg, one out of nine animals was found dead on Day 1. No further mortality occurred. - Clinical signs:
- other: At 2000 mg/kg, lethargy, lateral recumbency, flat posture, hunched posture, uncoordinated movements, shallow respiration, slow breathing, piloerection, pale appearance and/or ptosis were noted for all animals on Day 1. At 300 mg/kg, lethargy, lateral recu
- Gross pathology:
- At 2000 mg/kg, distention of the stomach with gas was found in the animal which was found dead on Day 2. At 300 mg/kg, watery-clear fluid in the stomach was found in the animal which was found dead on Day 1. Macroscopic post mortem examination of the other animals that died during the study and of the surviving animals at termination did not reveal any abnormalities.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The oral LD50 value of test item in Wistar rats was established to be within the range of 300-2000 mg/kg body weight.
- Executive summary:
According to the OECD 423 test guideline, initially, the test substacne was administered by oral gavage to three female Wistar rats at 2000 mg/kg body weight. In a stepwise procedure three additional groups of three females were dosed at 300 mg/kg body weight.
All animals were subjected to daily observations and weekly determination of body weight. Macroscopic examination was performed on the day of death or after terminal sacrifice (Day 15).
At 2000 mg/kg, all animals were found dead on Day 1 or 2. At 300 mg/kg, one out of nine animals was found dead on Day 1. No further mortality occurred.
At 2000 mg/kg, lethargy, lateral recumbency, flat posture, hunched posture, uncoordinated movements, shallow respiration, slow breathing, piloerection, pale appearance and/or ptosis were noted for all animals on Day 1. At 300 mg/kg, lethargy, lateral recumbency, tremor, hunched posture, uncoordinated movements, shallow respiration, quick breathing, piloerection, salivation, ptosis and/or hypothermia were noted for all animals on Day 1. Additionally piloerection was noted for two animals on Day 2.
At 2000 mg/kg, distention of the stomach with gas was found in the animal which was found dead on Day 2. At 300 mg/kg, watery-clear fluid in the stomach was found in the animal which was found dead on Day 1. Macroscopic post mortem examination of the other animals that died during the study and of the surviving animals at termination did not reveal any abnormalities.
The oral LD50 value of test substance in Wistar rats was established to be within the range of 300-2000 mg/kg body weight. The LD50 cut-off value was considered the LD50 cut-off value was considered to be 500 mg/kg body weight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.